DOI
https://doi.org/10.18849/ve.v6i2.373Abstract
PICO question
In horses undergoing lameness investigation, does sedation with a2-adrenergic agonists alone versus sedation with a2-adrenergic agonists in combination with butorphanol tartrate effect the degree of lameness?
Clinical bottom line
Category of research question
Diagnosis
The number and type of study designs reviewed
Six papers were critically reviewed. There were two crossover clinical studies, three crossover controlled clinical studies and a randomised controlled clinical study
Strength of evidence
Moderate
Outcomes reported
There was limited evidence to suggest that xylazine and romifidine in combination with butorphanol has an effect on forelimb lameness and that detomidine has an effect on hindlimb lameness.
Most evidence suggests that xylazine alone or in combination with butorphanol has no effect on the lameness
Conclusion
In general, sedating a horse with an a2-adrenergic agonist alone or in combination with butorphanol tartrate does not change the baseline degree of lameness. Due to the large variation in the measurements, the small magnitude of few significant effects and the inconsistency of these significant findings, there is insufficient evidence to recommend avoiding the use of sedation in cases where it would increase the safety of those involved. However, regardless of protocol used, clinicians must appreciate the possibility of individual horse variation
How to apply this evidence in practice
The application of evidence into practice should take into account multiple factors, not limited to: individual clinical expertise, patient’s circumstances and owners’ values, country, location or clinic where you work, the individual case in front of you, the availability of therapies and resources.
Knowledge Summaries are a resource to help reinforce or inform decision making. They do not override the responsibility or judgement of the practitioner to do what is best for the animal in their care.
References
Bassage, L.H. & Ross, M.W. (2010). Diagnostic Analgesia. In: Diagnosis and Management of Lameness in the Horse: Second Edition. 2nd ed. Saint Louis: W.B. Saunders, 100–135. DOI: https://doi.org/10.1016/B978-1-4160-6069-7.00010-9
Beck Júnior, A.A., De La Côrte, F. D., Brass, K.E., Dau, S.L., Silva, G.B. & Camillo, M.de A.. (2019). Effect of Xylazine and Butorphanol on Experimental Hind Limb Lameness in Horses. Journal of Equine Veterinary Science. 73, 56–62. DOI: https://doi.org/10.1016/j.jevs.2018.11.007
Buchner, H.H., Kübber, P., Zohmann, E. & Peham, C.H. (1999). Sedation and antisedation as tools in equine lameness examination. Equine Veterinary Journal. 30(S30), 227–230. DOI: https://doi.org/10.1111/j.2042-3306.1999.tb05223.x
De Cozar, M.J. (2019). Can I give alpha-2 agonists for blocking and accurately assess the horse’s lameness once blocked? Equine Veterinary Education. 31(2), 111–112. DOI: https://doi.org/10.1111/eve.12877
Moorman, V.J., Bass, L. & King, M.R. (2019). Evaluation of the effects of commonly used α2-adrenergic receptor agonists alone and in combination with butorphanol tartrate on objective measurements of lameness in horses. American Journal of Veterinary Research. 80(9), 868–877. DOI: https://doi.org/10.2460/ajvr.80.9.868
Morgan, J.M., Ross, M.W., Levine, D.G., Stefanovski, D., You, Y., Robinson, M.A. & Davidson, E.J. (2020). Effects of acepromazine and xylazine on subjective and objective assessments of forelimb lameness. Equine Veterinary Journal. 52(4), 593–600. DOI: https://doi.org/10.1111/evj.13225
Pilsworth, R. & Dyson, S. (2015). Where does it hurt? Problems with interpretation of regional and intra-synovial diagnostic analgesia. Equine Veterinary Education, 27(11), 595–603. DOI: https://doi.org/10.1111/eve.12392
Rettig, M.J., Leelamankong, P., Pungsri, P. & Lischer, C.J. (2015). Effect of sedation on fore- and hindlimb lameness evaluation using body-mounted inertial sensors. Equine Veterinary Journal. 48(5), 603–607. DOI: https://doi.org/10.1111/evj.12463
Ross, M.W. (2010). Movement. In: Diagnosis and Management of Lameness in the Horse: Second Edition, 2nd ed. Saint Louis: W.B. Saunders, 64–80. DOI: https://doi.org/10.1016/B978-1-4160-6069-7.00007-9
Seitzinger, A.H., Traub-Dargatz, J.L., Kane, A.J., Kopral, C.A., Morley, P.S., Garber, L.P., Losinger, W.C. & Hill, G.W. (2000). A comparison of the economic costs of equine lameness, colic and equine protozoal myelocencephalitis (EPM). Proceedings of the 9th International Symposium on Veterinary Epidemiology and Economics.
Da Silva Azevedo, M., De La Côrte, F.D., Brass, K.E., Gallio, M., Pozzobon, R., Lopes, M.A.F. & Lopes, L.F.D. (2015). The Use of Xylazine or Acepromazine Does Not Interfere in the Lameness Evaluation by Inertial Sensors. Journal of Equine Veterinary Science. 35(1), 27–30. DOI: https://doi.org/10.1016/j.jevs.2014.10.007
License
Copyright (c) 2021 Helene Termansen, Lucinda Meehan
This work is licensed under a Creative Commons Attribution 4.0 International License.
Veterinary Evidence uses the Creative Commons copyright Creative Commons Attribution 4.0 International License. That means users are free to copy and redistribute the material in any medium or format. Remix, transform, and build upon the material for any purpose, even commercially - with the appropriate citation.
